IMU 4.26% 4.5¢ imugene limited

Ann: Imugene doses first patient in HER-Vaxx phase 2 trial, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,381 Posts.
    lightbulb Created with Sketch. 256
    Thing is that if this phase 2 trial turns out to be VERY successful, IMU may not have the option of attempting to bring it to market on its own. Demand may be so great if it turns out to be more of a cure than a treatment and the option of licence manufacture would be the obvious way to go.

    All of that is a best case scenario commentary of course. Let's see whare the trial leads us in six months time.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
-0.002(4.26%)
Mkt cap ! $386.7M
Open High Low Value Volume
4.7¢ 4.8¢ 4.4¢ $890.8K 19.42M

Buyers (Bids)

No. Vol. Price($)
2 176601 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 969572 8
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.